How much do companies pay doctors in connection with ECIMA?

Across Open Payments program years 2019–2025, manufacturers reported $1,517,470 in payments to 0 U.S. providers naming ECIMA, across 15 separate transactions — an average of $101,165 per transaction. Most reported payments nationally are meals worth under $20.

Does being paid in connection with ECIMA mean a doctor is promoting it?

Not necessarily. Manufacturers must report the product associated with almost every transfer of value, including a meal provided during a presentation about that product. Consulting, speaking and research arrangements are also reported this way. The disclosure records an association, not a motive.

ECIMA: cost and payments to doctors

What Medicare Part D paid pharmacies for ECIMA, and the payments that named it as the associated device or medical supply under the Sunshine Act for program years 2019–2025.

Was your doctor paid by Omnilife Science, Inc?

Omnilife Science, Inc reported the most payments naming ECIMA. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported: $1.5M
Providers: 0
Transactions: 15
Average per transaction: $101,165

The per-transaction average — $101,165 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. No payment naming this product was reported to an individual clinician. The Sunshine Act also covers payments to teaching hospitals as institutions — research funding, grants and device loans — and for this product that is all of it.

Companies reporting these payments

Company	Total reported	Share
Omnilife Science, Inc	$1,517,470	100.0%

Other products from Omnilife Science, Inc

The company that reported the most payments naming ECIMA also reports against these.

← All drugs & devices